This story was reprinted with permission from Crain New York and written by Amanda D’Ambrosio. Last month, federal regulators released research guidance...
PharmAla Biotech Holdings Inc. (CSE: MDMA / OTC: PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX...
Stella also plans to open a new treatment clinic in Irvine, California. The post Stella to Acquire Some of Field Trip’s Psychedelics Therapy Clinics...
In clinical settings, a racemic mixture of both R and S ketamine is commonly used The post PharmaTher Holdings enters collaboration to commercialize racemic...
PharmAla Psychedelic drug company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF) announced a non-brokered private placement of a minimum 3,333,333...
Company pumps the brakes on KetaMD. The post Braxia Reports Increased Clinic Treatments appeared first on Green Market Report.
Some of the most promising penny stocks are up-and-coming and just just getting started. The world of penny stocks is all about speculating which young...
The Canadian psychedelics company reported a loss of C$7.6 million for the first quarter. The post Mydecine Loss Rate Increases, Only C$10k Left On Hand...
The Amanita muscaria extract was the subject of research published last month in Frontiers in Pharmacology The post Psyched Wellness extract shows positive...
The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies. The post Awakn Life Sciences’ Revenue...